All NewsFDA BriefsOncology IconsSpecial ReportsThe Targeted PulseVoices from the Field
Conference CoverageConference ListingData Dialogue with the Oncology Brothers
All VideosCase-Based Peer PerspectivesExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPivotal Practice Views with the Oncology BrothersPodcastsPrecision MedicineSpeaking Out
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
CASE-BASED ROUNDTABLEPARTNERS
CME/CEClinical TrialsPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
SUBSCRIBE
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
Spotlight -
  • Biomarker-Driven Lung Cancer
  • GIST
  • HER2 Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Small Cell Lung Cancer
  • Renal Cell Carcinoma
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
    • CASE-BASED ROUNDTABLE
    • PARTNERS
    • SUBSCRIBE
Advertisement

Platinum-Resistant Advanced Ovarian Cancer

home / case-based-peer-perspectives / krivak-advanced-ovarian-cancer

Platinum-Resistant Advanced Ovarian Cancer

Advanced Ovarian Cancer: Case Perspectives

EP. 1: Advanced Ovarian Cancer: Case Perspectives

March 15th 2019

Watch

Cytoreductive Surgery Goals in Advanced Ovarian Cancer

EP. 2: Cytoreductive Surgery Goals in Advanced Ovarian Cancer

March 15th 2019

Watch

High-Risk Advanced Ovarian Cancer: Chemotherapy Options

EP. 3: High-Risk Advanced Ovarian Cancer: Chemotherapy Options

March 15th 2019

Watch

Frontline VEGF Inhibition in Advanced Ovarian Cancer

EP. 4: Frontline VEGF Inhibition in Advanced Ovarian Cancer

March 15th 2019

Watch

Tailoring Treatment Based on BRCA-Mutation Status

EP. 5: Tailoring Treatment Based on BRCA-Mutation Status

March 15th 2019

Watch

Managing Toxicities in Advanced Ovarian Cancer

EP. 6: Managing Toxicities in Advanced Ovarian Cancer

March 15th 2019

Watch

Increase in PFS for Platinum-Resistant Advanced OC

EP. 7: Increase in PFS for Platinum-Resistant Advanced OC

March 15th 2019

Watch

Bright Future Ahead for the Treatment of Ovarian Cancer

EP. 8: Bright Future Ahead for the Treatment of Ovarian Cancer

March 15th 2019

Watch

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2024 MJH Life Sciences

All rights reserved.